UNIVERSITY OF CINCINNATI Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis. The research was published in the Annals of Internal Medicine. “For reasons that are not completely...